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Abstract
Background: Pyramidal neurons in the hippocampal area CA3 express high levels of BDNF, but how this BDNF contributes
to oscillatory properties of hippocampus is unknown.
Methodology/Principal Findings: Here we examined carbachol-induced gamma oscillations in hippocampal slices lacking
BDNF gene in the area CA3. The power of oscillations was reduced in the hippocampal area CA1, which coincided with
increases in the expression and activity of 5-HT3 receptor. Pharmacological block of this receptor partially restored power of
gamma oscillations in slices from KO mice, but had no effect in slices from WT mice.
Conclusion/Significance: These data suggest that BDNF facilitates gamma oscillations in the hippocampus by attenuating
signaling through 5-HT3 receptor. Thus, BDNF modulates hippocampal oscillations through serotonergic system.
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Introduction
Brain-derived neurotrophic factor has multiple neuroregulatory
functions [1,2,3,4] and one of its major targets are GABAergic
neurons [5,6], which play essential role in oscillatory activity
of neuronal networks [7,8,9]. Among several types of brain
oscillations, gamma oscillations, which include frequencies ranging
from 25 to 100 Hz [10], draw a lot of attention, because they are
considered an integrating mechanism, which couples different
brain structures during memory encoding and retrieval [11,12,13].
In addition, changes in gamma oscillatory activity in human brain
have been found in several psychiatric illnesses including
schizophrenia and bipolar disorder [14,15].
Hippocampus is one of the brain areas generating gamma
oscillations, which are driven by a network of connected
inhibitory neurons and require GABAergic transmission [7,16].
Fast-spiking parvalbumin-positive interneurons in particular are
thought to be responsible for driving gamma oscillations [9,17]
and genetic attenuation of excitatory inputs in these neurons have
been shown to reduce oscillation power in the hippocampal area
CA3 [18].
Hippocampus, where oscillations are thought to be involved in
cognition and memory [19–20], expresses high levels of BDNF
[21], which has been proposed to modulate oscillations by
influencing the firing of GABAergic neurons [22]. Nevetherless,
experimental evidence that BDNF modulates gamma oscillations
via inhibitory neurons is lacking.
In the hippocampus, BDNF is highly expressed in CA3
pyramidal neurons, which appear to deliver BDNF protein to
area CA1 via the Schaffer collateral axons [21]. Given that BDNF
influences firing of GABAergic neurons, which are required for
gamma oscillations in CA3 and CA1 [23], we hypothesized that
BDNF may modulate these oscillations. To test this hypothesis, we
examined carbachol-induced gamma oscillations in hippocampal
slices from conditional BDNF knockout mice lacking BDNF gene
in the CA3 pyramidal neurons (KO mice). In these slices, the
oscillation power was reduced in CA1, but not CA3, when
compared to slices from wild type mice; yet, this reduction was
partially reversed in the presence of tropisetron, an inhibitor of 5-
HT3 receptor, whose expression was elevated in KO mice.
Results
Power of gamma oscillations in area CA1, but not CA3 is
reduced in BDNF KO mice
Mice used in this study lack BDNF gene in the hippocampal
area CA3, but not in CA1 or dentate gyrus; the expression level of
BDNF in these animals has been characterized in a separate study
and was reduced in the whole hippocampus of 6–7 week old mice
by more than 25% (manuscript submitted to GBB).
Bath application of carbachol (25 mM) in hippocampal slices
from WT and KO mice induced gamma oscillations in areas
CA3 and CA1 with peak frequency of 31.0061.17 Hz and
34.4060.98 Hz respectively. In the presence of carbachol,
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5 min and lasted during the entire recording period of 30 min.
Longer recording sessions confirmed stability of oscillations for at
least 60 min (data not shown). The integral 20–80 Hz power of
oscillations in area CA3 did not differ significantly between
genotypes (WT: 141.84624.28 mV
2, n=13; KO: 126.896
18.7 mV
2, n=11, p.0.05) (Fig. 1A, C, E). In contrast, oscillation
power in area CA1 was significantly lower in slices from KO than
in WT mice (WT: 112.83617.85 mV
2, n=11; KO: 29.346
3.30 mV
2, n=14, p,0.001) (Fig. 1B, D, F).
Elevated 5-HT3 receptor-mediated GABAergic
transmission in BDNF KO mice
Oscillations in the brain strongly depend on GABAergic
neurons [7,24], whose activity is modulated by serotonergic
system, which, in turn is regulated by BDNF [25]. Given the
evidence that serotonergic system modulates oscillations, including
gamma rhythm [26], we hypothesized that BDNF augments
gamma oscillations in area CA1 by influencing serotonergic and
GABAergic transmission.
In search for possible changes in GABAergic transmission in
KO mice, we recorded spontaneous inhibitory postsynaptic
currents (sIPSC) in CA1 pyramidal neurons in the absence and
presence of 5-HT, which enhances sIPSC in these areas by acting
on 5-HT2 and 5-HT3 receptors of GABAergic neurons [27]
[28,29].
Bath application of 5-HT (20 mM) increased amplitude and
frequency of sIPSC in both genotypes (p,0.05) and these
increases were higher in slices from KO than WT mice (fold
increase; amplitude, WT: 1.3360.09, n=10, KO: 2.0260.25,
Figure 1. Power of gamma oscillations is reduced in area CA1 but not CA3 in slices from KO mice. A–B. Example traces of field
oscillations induced by 25 mM carbachol in hippocampal areas CA3 (A) and CA1 (B). C–D. Power spectra for oscillations in A (C) and B (D). E–F. Pooled
data for integral oscillation power (20–80 Hz) in area CA3 (E) and CA1 (F). ***p,0.001. Data represent mean 6 SEM.
doi:10.1371/journal.pone.0016480.g001
BDNF Knockout Reduces Gamma Oscillations
PLoS ONE | www.plosone.org 2 January 2011 | Volume 6 | Issue 1 | e16480n=12, p,0.05; frequency, WT: 1.4460.05, KO: 1.8460.15,
p,0.05, when compared between genotypes) (Fig. 2A).
To identify serotonin receptor(s) responsible for the differences
between genotypes, we modulated 5-HT2 and 5-HT3 receptors.
Pre-treatment of slices with a 5-HT2 receptors antagonist,
ketanserin (20 mM), abolished potentiation of sIPSC by 5-HT in
both genotypes (amplitude and frequency, WT: n=8, KO: n=9,
p.0.05, compared to baseline) (Fig. 2B), indicating that 5-HT2
receptor is necessary for 5-HT-induced sIPSC. Application of a 5-
HT2 receptor agonist a-methyl-5-HT (a-Me-5-HT) (20 mM)
enhanced sIPSC in both genotypes to a similar degree (fold
increase; amplitude, WT: 1.4560.14, n=10, KO: 1.4860.23,
n=9, p.0.05; frequency, WT: 1.5260.14, KO: 1.3060.07,
p.0.05) (Fig. 2C), suggesting no difference between genotypes in
the function of 5-HT2 receptors with respect to sIPSC.
A selective 5-HT3 receptors antagonist tropisetron (30 nM)
attenuated the 5-HT potentiation more strongly in KO than in
WT group and diminished the difference between genotypes in the
effect of 5-HT on sIPSC (fold increase; amplitude, WT:
1.2960.09, n=8, KO: 1.4360.11, n=9, p.0.05; frequency,
WT: 1.2660.07, KO: 1.4460.09, p.0.05) (Fig. 2D). Meanwhile,
a selective 5-HT3 receptor agonist m-chlorophenyl biguanide (m-
Figure 2. Enhancement of 5-HT-induced sIPSC in pyramidal neurons of CA1 of KO mice is mediated by 5-HT3 receptors. A–E.
Pharmacological modulation of sIPSC. Left: Examples of sIPSC traces. Right: summary data. sIPSC modulation by 20 mM 5-HT (A), by 5-HT in the
presence of 20 mM 5-HT2 receptors antagonist ketanserin (keta) (B), by 20 mM 5-HT2 receptors agonist a-methyl-5-HT (a-Me-5-HT) (C), by 5-HT in the
presence of 30 nM 5-HT3 receptor antagonist tropisetron (trop) and by 1 mM 5-HT3 receptor agonist m-chlorophenyl biguanide (m-CPBG). Number of
cells recorded from is indicated in parenthesis. *p,0.05, **p,0.01. Data represent mean 6 SEM.
doi:10.1371/journal.pone.0016480.g002
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n=15, p,0.01, compared to baseline), but not in WT group
(1.0060.03, n=13, p.0.05) (Fig. 2E), suggesting that the function
of 5-HT3 receptor with respect to sIPSCs is enhanced in KO
mice.
Upregulation of 5-HT3 receptor was further confirmed at the
expression level. Real time PCR (RT-PCR) analysis using total
hippocampal mRNA revealed higher expression of the 5-HT3A
subunit in KO than in WT mice (fold difference relative to WT,
KO: 1.8560.17, n=12, p,0.001, one sample t-test) (Fig. 3).
5-HT3 receptor block reverses gamma oscillations in KO
mice
To determine whether 5-HT3 receptor inhibits gamma
oscillations in area CA1 in KO mice, we examined the effect of
5-HT3 receptors antagonist tropisetron (30 nM) on gamma
oscillations. In slices from KO mice, tropisetron partially reversed
the oscillation deficiency. The integral oscillation power (20–
80 Hz) in tropisetron treated slices was 63.97610.52 mV
2 (n=12),
which was significantly higher than in control slices (29.346
3.30 mV
2, n=14, p,0.01) (Fig. 4A, C, E). Meanwhile, in slices
from WT mice, tropisetron did not change the power of
oscillations (p.0.05) (Fig. 4B, D, F). These results indicate that,
while normal activity of 5-HT3 receptor does not interfere with
gamma oscillations in our system, the upregulation of the receptor
in KO mice is partially responsible for the reduction in oscillation
power.
Besides being a specific antagonist of 5-HT3 receptor,
tropisetron can also activate the alpha-7 nicotinic receptor
[30,31]. To rule out a possibility that the reversal of oscillation
deficit in KO mice was achieved by activation of the alpha-7
nicotinic receptor (a-7nAChR), we re-examined the effect of
tropisetron in the presence of a-7 nAChR antagonist methyllyca-
conitine (MLA, 50 nM). MLA did not prevent tropisetron from
rescuing gamma oscillations in slices from KO mice (the integral
oscillation power (20–80 Hz): 66.9768.60 mV
2,n = 8 ,p ,0.001,
compared with the slices from KO mice (Fig. 5B, E). Moreover, a
5-HT3 receptor antagonist ondansetron (30 nM), which is not
known to activate a-7 nAChR, showed the same rescuing effect on
oscillations as tropisetron (integral oscillation power (20–80 Hz):
63.91613.37 mV
2,n=8 ,p ,0.01, compared with the slices from
KO mice (Fig. 5C, E). These data indicate that gamma oscillations
in slices from KO mice were rescued by inhibition of 5-HT3
receptor.
To examine whether oscillation deficit in KO slices could be
reversed by acute application of recombinant BDNF protein, we
co-applied carbachol in the presence of BDNF. BDNF (40 ng/ml)
did not rescue the oscillation deficit (the integral oscillation power
(20–80 Hz): 34.3965.20 mV
2, n=10, p.0.05, compared with the
slices form KO mice (Fig. 5D, E), suggesting that changes caused
by BDNF KO could not be reversed acutely in the slice.
Discussion
Hippocampal gamma oscillations originate in area CA3 and
propagate to area CA1 [12,24]. Our study suggests that BDNF
from CA3 pyramidal neurons does not affect these oscillations in
CA3, but facilitates them in CA1 by attenuating expression and
activity of 5-HT3 receptor, which is expressed in a subpopulation
of PV-negative GABAergic neurons, but not in the principal
neurons [32,33].
Several observations suggest that BDNF facilitates oscillatory
activity. In cultured hippocampal neurons, it increases fidelity
of spikes during periodic current injections [34] and facilitates
spontaneous Ca2+ oscillations [35]; in developing cortical
neurons, it potentiates frequency of synchronous spontaneous
oscillations [36]. BDNF also modulates GABAergic transmis-
sion [5] [37], which underlies oscillatory activities, but, to our
knowledge, there has been no direct evidence so far that BDNF
influences oscillations through GABAergic neurons. The present
study provides such evidence and suggests that the effect is
mediated by serotonergic system.
First, gamma oscillations were attenuated in slices from KO
mice. Second, in these slices, 5-HT enhanced sIPSCs more
strongly than in control slices, but this difference was attenuated by
a HT3 receptor antagonist, which also reversed the oscillation
deficit. These data suggest that the up-regulation of 5-HT3
receptor and subsequent changes in GABAergic neurons, which
express this receptor, were responsible for attenuated oscillations
in slices from KO mice.
However, the reversal of oscillation deficit by 5-HT3 receptor
antagonist was only partial, possibly because of irreversible
changes caused by chronic up-regulation of 5-HT3 receptor.
The partial rescue may also indicate that BDNF regulates gamma
oscillations through additional 5-HT3 receptor-independent
mechanisms, for example, by directly modulating fast-spiking
interneurons [22,38,39]. We could not reverse the oscillation
deficit by acute application of recombinant BDNF. It is consistent
with the idea that effect of BDNF on gamma oscillations is indirect
and may be mediated by molecules like 5-HT3 receptor, whose
expression or activity are altered during long-lasting reduction in
BDNF concentration in KO mice and cannot be reversed rapidly.
Surprisingly, in contrast to the oscillation deficit in CA1, slices
from KO animals had normal oscillations in CA3, despite the
deletion of BDNF gene in this area. This difference may result
from the lower serotonergic innervations of the CA3 pyramidal
layer [40], which may render CA3 oscillations less dependent on
5-HT than the oscillations in area CA1, which has more
serotonergic axons. Such explanation is consistent with an idea
that the main effect of BDNF on oscillations is mediated by
serotonergic system.
Changes in gamma oscillations have been found in several brain
illnesses, including schizophrenia, bipolar disorder and Alzheimer
[14,15,41,42], some of which include cognitive impairments. On
the other hands, BDNF has been implicated in cognitive function,
because it regulates synaptic plasticity [43] and animals with
deletions of BDNF gene in brain areas that include hippocampus
show deficits in synaptic plasticity [44] and cognitive impairments
[45,46], whereas animals with increased expression of BDNF
show better performance in cognitive tasks [47]. Modulation of
Figure 3. Increase in the expression of 5-HT3a mRNA in the
hippocampus of KO mice. mRNA expression of 5-HT3a receptor in
KO mice relative to that in WT as determined by RT-PCR. ***p,0.001.
doi:10.1371/journal.pone.0016480.g003
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responsible for those behavioral changes.
Materials and Methods
Generation of mice with BDNF gene deletion in CA3
pyramidal neurons
All experiments were performed under the Animal Study
Protocol LMP 10-09 approved by the National Institute of Mental
Health Animal Care and Use Committee. Male mice with
homozygous floxed BDNF gene [44] carrying G32-4 allele of
Cre-recombinase [48] (BDNF
ff, Cre animals) were crossed with
BDNF
ff females, which yielded BDNF
ff, Cre mice further referred
to as KO, and BDNF
ff mice referred to as WT. The presence of
Cre and floxed BDNF alleles was determined as previously
described [44]. Only male mice were used and all animals were on
C57BL/6J background.
Electrophysiology
Mice (6–7 week old) were decapitated under isoflurane
anesthesia. Brains were rapidly removed and immersed in ice-
cold cutting solution containing, in mM: 252 sucrose, 2.5 KCl, 4
Figure 4. Reduction of gamma oscillation power in KO mice is partially reversed by 5-HT3 receptor antagonist tropisetron. A–B.
Upper: Example traces of field oscillations in hippocampal area CA1 induced by carbachol in the presence of 30 nM tropisetron in slices from KO
(KO+trop) (A) and WT (WT+trop) mice (B). Lower: Traces of oscillations obtained in the absence of tropisetron, are shown for comparison. C–D. Power
spectra for oscillations in A (C) and B (D). E–F. Pooled data for integral oscillation power (20–80 Hz) in area CA1 in the presence of tropisetron (grey
bars); data from Fig. 1 obtained in the absence of tropisetron are shown for comparison (white bars). Number of cells recorded from is indicated in
parenthesis. **p,0.01. Data represent mean 6 SEM.
doi:10.1371/journal.pone.0016480.g004
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saturated with 95% O2 and 5% CO2. 400 mm horizontal slices
were prepared using Microslicer (DSK, Kyoto, Japan). The slices
were incubated in ACSF containing, in mM: 124 NaCl, 3.5 KCl, 2
MgCl2, 2 CaCl2, 1.25 NaH2PO4, 25 NaHCO3, 10 Glucose,
saturated with 95% O2 and 5% CO2 at room temperature for at
least 1 h before recording.
Slices were transferred to a submerged two surface superfused
recording chamber at 33uC [49] and perfused at a rate of 4.5–
5.5 ml/min with ACSF identical to the incubation solution except
for the concentration of MgCl2 which was 1.5 mM. Recordings
were performed using a Muticlamp 700B amplifier (Molecular
Devices, Sunnyvale, CA). Field oscillations were recorded using
2.5–3.5 MV glass pipettes filled with ACSF. For the whole cell
recordings, the pipette resistance was 3–5 MV and the internal
solution contained (in mM): 140 KCl, 10 HEPES, 1 EGTA, 2
MgCl2?6H2O, 2 Na2ATP, 0.4 Tris GTP (pH adjusted to 7.3 by
KOH), 5 QX-314, and ACSF included 6-cyano-7-nitroquinoxa-
line-2,3-dione (CNQX) (20 mM) and D-APV (10 mM). Cells were
clamped at 270 mV, series resistance was #25 MV, and the data
were discarded when Rs value changed by more than 20%.
GABAA nature of the inward synaptic currents was verified by
their block with picrotoxin (200 mM). Current responses were
analyzed with Mini Analysis v6.0 software (Synaptosoft, Fort Lee,
NJ). The power spectra and integral power for 20–80 Hz
frequency range were calculated for 60 second long recording
segments using fast Fourier transformation in Clampfit 9.2
(Molecular Devices).
Quantitative real time PCR
Total RNA from whole hippocampi was isolated using RNeasy
Lipid Tissue Mini Kit (Qiagen, Valencia, CA) and reverse
transcribed (2 mg) using SuperScript III First Strand-Synthesis
System For RT-PCR (Invtirogen, Carlsbad, CA). PCR was
performed using Smart Cycler and data were analyzed using
Smart Cycler System Software (Cepheid, Sunnyvale, CA). cDNA
was amplified using FastStart Taq DNA Polymerase (Roche,
Mannheim, Germany) in the presence of SYBR Green I
(Invtirogen) at 1: 40,000 dilution. Primers for GAPDH (forward:
59-AATGTGTCCGTCGTGGATCTGA-39; reverse: 59-GATG-
CCTGCTTCACCACCTTCT-39) and 5-HTr3A (forward: 59-
TGGACTCCTGAGGACTTCGACAAT-39; reverse: 59-9TGA-
ACTTCACCTCGATGATGCACG-39) were at 500 nM. The
cycling conditions were: 5 min at 95uC followed by 40 cycles of
95uC/15 sec, 60uC/30 sec. The cycle threshold (Ct) was deter-
mined as the zero for the second derivative of the growth curve
function. The fold change in mRNA expression of receptors was
determined using the comparative Ct method [50] with GAPDH
mRNA as the normalization control.
Statistical methods
Data are presented as mean 6 SEM. Comparisons were
performed using two-tail unpaired t-test (if not specified), one
sample t-test (real time PCR).
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